Fundz

Hopewell Therapeutics, Inc. reported raising $7.8 Million in an initial SEC Form D filing, from an offering of $500,000

PRIVATEDec 21, 2020

Amount Raised

$7.8 Million

$7.8 Million sold, per SEC Form D (first sale Dec 21, 2020)

Round Type

Venture

WoburnBiotechnology

Quick answer

Hopewell Therapeutics raised $7.8 Million in a funding round, dated December 21, 2020. Hopewell Therapeutics is based in Woburn, Massachusetts, United States.

How much did Hopewell Therapeutics raise?
Hopewell Therapeutics raised $7.8 Million in a funding round on December 21, 2020.
What does Hopewell Therapeutics do?
Hopewell Therapeutics is discovering, synthesizing and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients.
Where is Hopewell Therapeutics based and how big is it?
Hopewell Therapeutics is based in Woburn, Massachusetts, United States. Fundz records about 25 employees.
Who are the decision-makers at Hopewell Therapeutics?
Fundz holds 1 contact at Hopewell Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Hopewell Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Exacis Biotherapeutics Inc. raised $50K (Seed) on February 4, 2021.
  • NeuraMedica raised $1.1M (Seed) on February 4, 2021.
  • DarioHealth raised $70M on February 3, 2021.
  • CANCER GENETICS, INC raised $10M on February 3, 2021.
  • Circle8 Group Inc raised $350K (Seed) on February 3, 2021.
  • Pairwise raised $90M (Funding Round) on February 3, 2021.

Who to call at Hopewell Therapeutics, and when

A new round usually means Hopewell Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hopewell Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hopewell Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hopewell Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hopewell Therapeutics

Location

216 WEST CUMMINGS PARK

Woburn, Massachusetts, United States

About

Hopewell Therapeutics is discovering, synthesizing and developing the next generation of tissue-targeted lipid nanoparticles (ttLNPs) to bring genomic medicines to patients. We are pursuing opportunities to redefine the non-viral delivery space for novel genomic medicines by designing systemically administered LNPs to specifically target extrahepatic tissues and cells throughout the body. Hopewell has built a robust intellectual property portfolio with an expansive library of ionizable lipids and has established partnerships with several industry leading companies. We are developing our own internal pipeline, initially targeting diseases of the lung, while concurrently exploring the potential of our ttLNP platform for patients with unmet needs in oncology, infectious diseases, rare genetic diseases and neurological disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hopewell Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts3 people are listed at Hopewell Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Hopewell Therapeutics's next move

See what Strategic adds

Hopewell Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.